Tag: Stellarex DCB
Five-year ILLUMENATE results confirm safety profile of Philips Stellarex DCB
Royal Philips has announced the final, five-year results of two randomized controlled trials (RCTs) that show no difference in all-cause mortality between patients treated...
TCT 2020 late-breaking trials session features new data on drug-coated devices
Findings from a series of late-breaking trials in the endovascular field were delivered recently at TCT Connect (Oct. 14–18), the 32nd annual scientific symposium...